Halladay Benjamin

Halladay Benjamin is listed in filings as Chief Financial Officer at Esperion Therapeutics, Inc.. This profile follows SEC Form 4 activity through Mar 18, 2026, including sale activity. Recent filings connect the profile to Esperion Therapeutics, Inc. (ESPR). The current snapshot covers public activity from Dec 18, 2024 to Mar 18, 2026. Reported amounts are shown as $17.4K to $26.9K. The page organizes purchases, sales, issuer links, reported share activity, and filing evidence for review as public disclosure data.